Accidental and Surreptitious Intake of Oral Anticoagulants Including Older and Newer Agents - A Diagnostic Dilemma
Journal: Journal of Hematology & Thrombosis (Vol.3, No. 1)Publication Date: 2017-06-30
Authors : Nathan Visweshwar Ankita Patel Michael Jaglal; Damian Laber;
Page : 1-3
Keywords : Newer oral anticoagulants; NOAC; Warfarin; Accidental; Surreptitious; Bleeding;
Abstract
The newer oral anticoagulants including dabigatran, rivaraxoban, apixaban and edoxaban are replacing warfarin in the management of atrial fibrillation and venous thromboembolism. Accidental and surreptitious overdose of warfarin has been reported, but so far there is no reported case of overdose involving NOACs. Overdose of warfarin prolongs coagulation tests including PT and APTT. This gives a clue as to the underlying cause of bleeding, but with the newer oral anticoagulants these tests are of no value. The diagnosis and management of bleeding with accidental and surreptitious intake of oral anticoagulants is very difficult and high index of suspicion is needed.
Other Latest Articles
- Large Granular Lymphocytic Leukemia and Cocaine Abuse in A Patient With Chronic Neutropenia - Are They Co-Existing or Causally Related?
- Bacterial meningitis associated with pituitary macroadenoma: systematic review
- Do the Infant Respiratory Distress Syndrome and Presumed Sepsis affect Thyroid Function in Preterm Newborns within the First 10 Days of Life?
- Intranasal Steroid and Asthma
- Intolerance to Prone Positioning as a Clinical Marker of Motor Delay in Infants
Last modified: 2017-12-08 16:27:07